nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—Cloperastine—Raloxifene—breast cancer	0.416	0.421	CrCrCtD
Anileridine—Loperamide—Toremifene—breast cancer	0.352	0.356	CrCrCtD
Anileridine—Loperamide—Tamoxifen—breast cancer	0.221	0.223	CrCrCtD
Anileridine—Sufentanil—CYP3A4—breast cancer	0.000599	0.103	CrCbGaD
Anileridine—Hydroxyzine—CYP2D6—breast cancer	0.00051	0.0879	CrCbGaD
Anileridine—Astemizole—CYP2D6—breast cancer	0.000505	0.0871	CrCbGaD
Anileridine—Astemizole—CYP3A4—breast cancer	0.000433	0.0747	CrCbGaD
Anileridine—Darifenacin—CYP2D6—breast cancer	0.00037	0.0638	CrCbGaD
Anileridine—Astemizole—ABCB1—breast cancer	0.000361	0.0622	CrCbGaD
Anileridine—Haloperidol—CYP1A1—breast cancer	0.000337	0.058	CrCbGaD
Anileridine—Darifenacin—CYP3A4—breast cancer	0.000317	0.0547	CrCbGaD
Anileridine—Pethidine—CYP2D6—breast cancer	0.000293	0.0505	CrCbGaD
Anileridine—Pethidine—CYP3A4—breast cancer	0.000251	0.0433	CrCbGaD
Anileridine—Haloperidol—CYP2D6—breast cancer	0.00025	0.0432	CrCbGaD
Anileridine—Loperamide—CYP2D6—breast cancer	0.000229	0.0395	CrCbGaD
Anileridine—Pethidine—ALB—breast cancer	0.000219	0.0378	CrCbGaD
Anileridine—Haloperidol—CYP3A4—breast cancer	0.000215	0.037	CrCbGaD
Anileridine—Fentanyl—CYP3A4—breast cancer	0.000204	0.0352	CrCbGaD
Anileridine—Loperamide—CYP3A4—breast cancer	0.000196	0.0339	CrCbGaD
Anileridine—Haloperidol—ABCB1—breast cancer	0.000179	0.0308	CrCbGaD
Anileridine—Fentanyl—ABCB1—breast cancer	0.00017	0.0293	CrCbGaD
Anileridine—Loperamide—ABCB1—breast cancer	0.000164	0.0282	CrCbGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL12—breast cancer	2.87e-05	0.00534	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCR4—breast cancer	2.87e-05	0.00534	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—RAF1—breast cancer	2.73e-05	0.00509	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—RELA—breast cancer	2.72e-05	0.00506	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	2.68e-05	0.005	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	2.68e-05	0.005	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL20—breast cancer	2.66e-05	0.00497	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	2.66e-05	0.00496	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CD4—breast cancer	2.66e-05	0.00496	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GPER1—breast cancer	2.62e-05	0.00489	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—LPAR1—breast cancer	2.58e-05	0.00481	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	2.57e-05	0.00479	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STARD8—breast cancer	2.57e-05	0.00478	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NMBR—breast cancer	2.51e-05	0.00468	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL1B—breast cancer	2.46e-05	0.00458	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	2.41e-05	0.00449	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—JUN—breast cancer	2.38e-05	0.00444	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GPER1—breast cancer	2.38e-05	0.00444	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CNR2—breast cancer	2.37e-05	0.00443	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTGER1—breast cancer	2.34e-05	0.00435	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NMBR—breast cancer	2.28e-05	0.00425	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	2.28e-05	0.00425	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	2.28e-05	0.00425	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAPK8—breast cancer	2.25e-05	0.0042	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—WNT1—breast cancer	2.23e-05	0.00416	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—PIK3CA—breast cancer	2.19e-05	0.00408	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTGER1—breast cancer	2.12e-05	0.00395	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL27—breast cancer	2.08e-05	0.00388	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL3—breast cancer	2.08e-05	0.00388	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE2A—breast cancer	2.08e-05	0.00388	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	2.06e-05	0.00384	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL2—breast cancer	2.04e-05	0.00381	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGTR2—breast cancer	2.04e-05	0.00381	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—PTHLH—breast cancer	2.02e-05	0.00376	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAPK3—breast cancer	1.97e-05	0.00367	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—EDNRB—breast cancer	1.96e-05	0.00364	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—WNT10B—breast cancer	1.94e-05	0.00362	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—TGFB1—breast cancer	1.91e-05	0.00356	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL3—breast cancer	1.89e-05	0.00352	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL27—breast cancer	1.89e-05	0.00352	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE2A—breast cancer	1.89e-05	0.00352	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—AKT1—breast cancer	1.79e-05	0.00333	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CALCA—breast cancer	1.78e-05	0.00331	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCR4—breast cancer	1.74e-05	0.00324	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL12—breast cancer	1.74e-05	0.00324	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGTR1—breast cancer	1.57e-05	0.00293	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RGS2—breast cancer	1.52e-05	0.00284	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL20—breast cancer	1.51e-05	0.00281	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—HRAS—breast cancer	1.5e-05	0.0028	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LGR6—breast cancer	1.47e-05	0.00275	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCDC88C—breast cancer	1.47e-05	0.00275	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—LPAR1—breast cancer	1.46e-05	0.00272	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL6—breast cancer	1.44e-05	0.00268	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCL8—breast cancer	1.41e-05	0.00263	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GPER1—breast cancer	1.41e-05	0.00262	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SFRP1—breast cancer	1.41e-05	0.00262	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RGS2—breast cancer	1.38e-05	0.00258	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE4D—breast cancer	1.38e-05	0.00257	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL20—breast cancer	1.37e-05	0.00255	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NMBR—breast cancer	1.35e-05	0.00251	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CNR2—breast cancer	1.34e-05	0.0025	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—AKT1—breast cancer	1.33e-05	0.00247	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—LPAR1—breast cancer	1.32e-05	0.00247	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HEYL—breast cancer	1.25e-05	0.00234	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CUL5—breast cancer	1.25e-05	0.00234	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTGER1—breast cancer	1.25e-05	0.00234	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE4D—breast cancer	1.25e-05	0.00233	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CNR2—breast cancer	1.22e-05	0.00227	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL8—breast cancer	1.19e-05	0.00221	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RSPO3—breast cancer	1.18e-05	0.0022	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL2—breast cancer	1.15e-05	0.00215	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AGTR2—breast cancer	1.15e-05	0.00215	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—WWOX—breast cancer	1.15e-05	0.00214	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—WNT10B—breast cancer	1.15e-05	0.00214	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—WNT1—breast cancer	1.15e-05	0.00214	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTHLH—breast cancer	1.14e-05	0.00213	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—INHBB—breast cancer	1.12e-05	0.00208	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL3—breast cancer	1.12e-05	0.00208	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE2A—breast cancer	1.12e-05	0.00208	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL27—breast cancer	1.12e-05	0.00208	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—EDNRB—breast cancer	1.11e-05	0.00206	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DLL4—breast cancer	1.07e-05	0.00199	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BMPR2—breast cancer	1.07e-05	0.00199	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGTR2—breast cancer	1.05e-05	0.00195	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL2—breast cancer	1.05e-05	0.00195	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTHLH—breast cancer	1.04e-05	0.00193	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDH5—breast cancer	1.02e-05	0.0019	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CALCA—breast cancer	1e-05	0.00187	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—EDNRB—breast cancer	1e-05	0.00187	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SFRP2—breast cancer	1e-05	0.00187	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRLR—breast cancer	9.84e-06	0.00183	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL12—breast cancer	9.81e-06	0.00183	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCR4—breast cancer	9.81e-06	0.00183	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GLI2—breast cancer	9.5e-06	0.00177	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VCP—breast cancer	9.5e-06	0.00177	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	9.45e-06	0.00176	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEPR—breast cancer	9.35e-06	0.00174	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CALCA—breast cancer	9.12e-06	0.0017	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL12—breast cancer	8.91e-06	0.00166	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCR4—breast cancer	8.91e-06	0.00166	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AGTR1—breast cancer	8.87e-06	0.00165	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ARHGDIA—breast cancer	8.69e-06	0.00162	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FST—breast cancer	8.47e-06	0.00158	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HEY2—breast cancer	8.36e-06	0.00156	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RPS6KB2—breast cancer	8.26e-06	0.00154	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RGS2—breast cancer	8.17e-06	0.00152	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL20—breast cancer	8.08e-06	0.00151	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGTR1—breast cancer	8.06e-06	0.0015	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ITPR1—breast cancer	7.96e-06	0.00148	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LPAR1—breast cancer	7.82e-06	0.00146	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TLE3—breast cancer	7.82e-06	0.00146	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HEY1—breast cancer	7.74e-06	0.00144	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DLL1—breast cancer	7.59e-06	0.00142	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HIST1H2BK—breast cancer	7.45e-06	0.00139	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HIST1H2BC—breast cancer	7.45e-06	0.00139	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRB7—breast cancer	7.39e-06	0.00138	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE4D—breast cancer	7.39e-06	0.00138	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CSF2—breast cancer	7.35e-06	0.00137	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TAB2—breast cancer	7.26e-06	0.00135	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ITPR1—breast cancer	7.23e-06	0.00135	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CNR2—breast cancer	7.2e-06	0.00134	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL8—breast cancer	7.2e-06	0.00134	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MMP3—breast cancer	7.18e-06	0.00134	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DKK1—breast cancer	7.03e-06	0.00131	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VEGFC—breast cancer	6.97e-06	0.0013	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JAG2—breast cancer	6.87e-06	0.00128	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—WNT1—breast cancer	6.77e-06	0.00126	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PLA2G4A—breast cancer	6.75e-06	0.00126	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CSF2—breast cancer	6.68e-06	0.00124	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOTCH4—breast cancer	6.42e-06	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GZMB—breast cancer	6.38e-06	0.00119	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGTR2—breast cancer	6.19e-06	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL2—breast cancer	6.19e-06	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTHLH—breast cancer	6.12e-06	0.00114	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BMP2—breast cancer	6.12e-06	0.00114	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EDNRB—breast cancer	5.93e-06	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PGR—breast cancer	5.87e-06	0.00109	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—THBS1—breast cancer	5.84e-06	0.00109	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FLT1—breast cancer	5.57e-06	0.00104	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF3—breast cancer	5.55e-06	0.00103	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SQSTM1—breast cancer	5.55e-06	0.00103	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CG—breast cancer	5.52e-06	0.00103	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JAG1—breast cancer	5.48e-06	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PARP1—breast cancer	5.46e-06	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOTCH3—breast cancer	5.46e-06	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CALCA—breast cancer	5.39e-06	0.001	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RPS6—breast cancer	5.33e-06	0.000992	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF4—breast cancer	5.28e-06	0.000985	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL12—breast cancer	5.26e-06	0.000981	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCR4—breast cancer	5.26e-06	0.000981	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PAK1—breast cancer	5.17e-06	0.000963	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TCF7L2—breast cancer	5.08e-06	0.000946	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT2—breast cancer	5.05e-06	0.000942	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	5.01e-06	0.000935	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOTCH2—breast cancer	4.89e-06	0.000912	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	4.89e-06	0.000912	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	4.85e-06	0.000905	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGTR1—breast cancer	4.76e-06	0.000887	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRL—breast cancer	4.76e-06	0.000887	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADAM10—breast cancer	4.69e-06	0.000874	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STK11—breast cancer	4.69e-06	0.000874	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLG—breast cancer	4.64e-06	0.000865	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT2—breast cancer	4.59e-06	0.000855	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF10—breast cancer	4.56e-06	0.000851	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	4.41e-06	0.000822	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFA—breast cancer	4.4e-06	0.000821	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TGFBR2—breast cancer	4.34e-06	0.000809	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ITPR1—breast cancer	4.27e-06	0.000796	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT5A—breast cancer	4.24e-06	0.000791	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ERBB4—breast cancer	4.24e-06	0.000791	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MMP3—breast cancer	4.24e-06	0.000791	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	4.23e-06	0.000789	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SMAD4—breast cancer	4.11e-06	0.000766	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IGF1R—breast cancer	4.08e-06	0.000761	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	4.07e-06	0.000758	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HES1—breast cancer	4.01e-06	0.000748	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	3.99e-06	0.000743	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NCOR1—breast cancer	3.99e-06	0.000743	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CSF2—breast cancer	3.94e-06	0.000735	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF1—breast cancer	3.94e-06	0.000735	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RAF1—breast cancer	3.94e-06	0.000733	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NRG1—breast cancer	3.92e-06	0.00073	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—H2AFX—breast cancer	3.89e-06	0.000725	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2—breast cancer	3.89e-06	0.000724	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—E2F1—breast cancer	3.86e-06	0.000719	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	3.84e-06	0.000716	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SPP1—breast cancer	3.71e-06	0.000691	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL8—breast cancer	3.69e-06	0.000688	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ERBB3—breast cancer	3.67e-06	0.000684	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGFR2—breast cancer	3.66e-06	0.000683	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2—breast cancer	3.53e-06	0.000658	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TERT—breast cancer	3.52e-06	0.000655	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGFR1—breast cancer	3.41e-06	0.000636	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HIF1A—breast cancer	3.36e-06	0.000627	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEP—breast cancer	3.28e-06	0.000612	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CAV1—breast cancer	3.25e-06	0.000606	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KDR—breast cancer	3.22e-06	0.000599	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ESR1—breast cancer	3.13e-06	0.000584	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FN1—breast cancer	3.1e-06	0.000577	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NFKBIA—breast cancer	3.06e-06	0.00057	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOTCH1—breast cancer	3.03e-06	0.000565	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APC—breast cancer	2.96e-06	0.000552	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CG—breast cancer	2.96e-06	0.000552	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KIT—breast cancer	2.96e-06	0.000552	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EGF—breast cancer	2.93e-06	0.000546	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MAPK3—breast cancer	2.84e-06	0.000529	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BRAF—breast cancer	2.78e-06	0.000519	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IGF1—breast cancer	2.71e-06	0.000505	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT2—breast cancer	2.71e-06	0.000505	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—EGFR—breast cancer	2.7e-06	0.000503	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CD—breast cancer	2.6e-06	0.000485	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.58e-06	0.000481	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SERPINE1—breast cancer	2.58e-06	0.00048	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—KRAS—breast cancer	2.55e-06	0.000475	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOS3—breast cancer	2.46e-06	0.000458	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	2.34e-06	0.000437	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MDM2—breast cancer	2.33e-06	0.000435	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RAF1—breast cancer	2.33e-06	0.000433	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RELA—breast cancer	2.31e-06	0.000431	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.3e-06	0.000429	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MTOR—breast cancer	2.27e-06	0.000423	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.27e-06	0.000423	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.18e-06	0.000407	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.17e-06	0.000404	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.13e-06	0.000397	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.11e-06	0.000393	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CASP3—breast cancer	2.09e-06	0.000389	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2—breast cancer	2.08e-06	0.000388	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6—breast cancer	2.07e-06	0.000387	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCND1—breast cancer	2.03e-06	0.000379	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JUN—breast cancer	2.03e-06	0.000378	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.01e-06	0.000375	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MMP9—breast cancer	1.97e-06	0.000368	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	1.97e-06	0.000366	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTEN—breast cancer	1.96e-06	0.000366	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK8—breast cancer	1.92e-06	0.000358	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT1—breast cancer	1.91e-06	0.000357	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SRC—breast cancer	1.82e-06	0.000339	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.77e-06	0.00033	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT3—breast cancer	1.75e-06	0.000327	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.68e-06	0.000312	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MYC—breast cancer	1.63e-06	0.000304	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TGFB1—breast cancer	1.63e-06	0.000303	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EGFR—breast cancer	1.59e-06	0.000297	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KRAS—breast cancer	1.51e-06	0.000281	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.38e-06	0.000258	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TP53—breast cancer	1.34e-06	0.000249	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HRAS—breast cancer	1.28e-06	0.000239	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6—breast cancer	1.23e-06	0.000228	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT1—breast cancer	1.13e-06	0.000211	CbGpPWpGaD
